The ePatient Revolution
Ryan Prior shares his experience and his thoughts from attending the Stanford Medicine X Conference as he contemplates the rising of the ePatient Revolution ...
Discuss the article on the Forums.

Overview of the Drug Development Landscape

Discussion in 'General ME/CFS News' started by lnester7, Mar 26, 2013.

  1. lnester7

    lnester7 Seven

    Messages:
    1,274
    Likes:
    1,170
    USA
    http://www.research1st.com/2013/03/18/upcoming-webinar-1/

    Date/Time: March 28, 2013 at 1:00 p.m. EDT
    Speaker: Kristin Schneeman, Program Director, FasterCures Host: Kim McCleary, CEO, The CFIDS Association of America
    Registration: http://bit.ly/spring-series-1

    In the first program of our Spring 2013 Webinar Series, we welcome Kristin Schneeman, program director for FasterCures, as our guest speaker. Kristin will outline the process to translate scientific discoveries into accessible medical solutions. She will define the major components of the research and development (R&D) cycle as a basis for helping community members understand the landscape for drug development. She will contrast it with the landscape for basic research, an area that is more familiar to most patient advocates and community members.
     

See more popular forum discussions.

Share This Page